D-0982-2017 Class III Terminated

Recalled by Shionogi Inc. — Alpharetta, GA

FDA drug recall D-0982-2017 was initiated by Shionogi Inc. on May 24, 2017 and is designated Class III. Reason for recall: Failed Dissolution Specifications: Low dissolution results were obtained during stability testing The recall status is terminated (terminated Feb 28, 2018). Affected quantity: 455 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 26, 2017
Initiation Date
May 24, 2017
Termination Date
Feb 28, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
455 bottles

Product description

PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc. Florham Park, NJ 07932 Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981

Reason for recall

Failed Dissolution Specifications: Low dissolution results were obtained during stability testing

Distribution pattern

Nationwide

Code information

Lot #: 5H66200103, Exp. June 2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0982-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0982-2017. Report a data issue: hello@regdatalab.com.